XML 17 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net income (loss) $ (4,317,424) $ 7,080,771
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 134,800 138,400
Stock based compensation 571,069 957,869
Equity compensation expense 671
Non-cash interest expense 202,920
Amortization of debt discount 62,562
Accrued interest on short-term note payable - related party 1,775
Change in fair value of derivative liabilities 356,430 (12,201,300)
Changes in operating assets and liabilities:    
Accounts receivable (41,994) (4,112)
Prepaid expenses 47,058 (139,453)
Other current assets (192,800) (431,608)
Accounts payable and accrued expenses (847,995) 1,118,918
Income taxes payable (6,369)
Excise taxes 124,052 27,296
Due to related party (12,873)
Net Cash Used In Operating Activities (4,115,341) (3,255,997)
Cash Flows From Investing Activities:    
Purchases of property and equipment (117,812)
Capitalized patent costs (45,432) (63,686)
Net Cash Used In Investing Activities (45,432) (181,498)
Cash Flows From Financing Activities:    
Proceeds from issuance of common stock and warrants in connection with the Private Placement 34,994,842
Offering costs for common stock and warrants issuance in connection with the Private Placement (2,814,747)
Proceeds from issuance of common stock from exercise of warrants 241,546
Proceeds from short-term notes payable 75,000
Proceeds from short-term notes payable – related party 75,000
Repayment of short-term notes payable (696,732) (42,671)
Cash used to settle fractional shares (460)
Net Cash Provided By Financing Activities 31,633,363 198,415
Net change in cash 27,472,590 (3,239,080)
Cash at beginning of period 204,725 3,353,732
Cash at end of period 27,677,315 114,652
Supplemental disclosure    
Cash paid for interest expense 95,781 7,329
Cash paid for federal income taxes 6,369
Supplemental disclosure of non-cash financing activities:    
Issuance of Common Stock upon the closing of the Merger 414
Issuance of stock purchase warrants 1,938,014
Issuance of Common Stock upon cashless exercise of warrants 2
Forward Purchase Agreement discount accretion 159,618
Debt discount recognized on note payable 85,000
Issuance of promissory note in settlement of due to related party 75,000
Convertible notes converted to common shares 527,500
Reclassification of warrant derivative liability to additional paid-in capital upon exercise of Series A warrants 357,139
Capitalized interest to principal balance of short-term note payable 202,920
Reverse stock split — reclassification from common stock to additional paid-in capital 13,311
Shares issued upon settlement of warrants $ 24